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COMPLIANCE LEVEL TO MOBILE HEALTH RESEARCH APPLICATION IN 
CARDIOVASCULAR PATIENTS 
EMMA MENG 
ABSTRACT 
Purpose: This thesis intends to evaluate the factors which positively and negatively 
influence patient compliance to performing weekly home-based digital 6-minute-walk-
tests (d6MWT) using a smartphone and smart watch. 
Problem: Long term patient engagement in mobile health apps have proven to be a 
challenge to maintain. In this thesis, factors that influence patient engagement will be 
identified when it comes to retaining participants that are using the VascTrac mobile 
health research application. 
Methods: Patient compliance will be calculated based on how many d6MWT are 
completed out of the expected total. The population is split into four levels of compliance 
groups from least compliant (0-25% compliance (Group A)) to most compliant (75.1-
100% compliance (Group D)). “Open Walk” and survey data are collected and compared 
amongst these groups to see if there are any direct relationships that could be found. An 
“End of Study Survey” is also conducted to better understand the reasons behind 
differing compliance levels. 
Results: The overall compliance level is 66.1% for all comers with half of the patients 
scoring above 80%. Patients with higher compliance tend to have a higher weekly “Open 
Walk” average (correlation coefficient = 0.3). The average of weekly “Open Walk” is 
0.53 walks/week. 
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Conclusion: Factors that negatively affect whether patients would be compliant to doing 
the weekly d6MWT are medical issues, technical difficulties, hospitalization, and lack of 
motivation. Being motivated and having a desire for self-improvement positively 
influences compliance levels. Decrease use of walking aids correlates to higher 
compliance and being smartphone naïve at beginning of study correlates to lower 
compliance. The other factors (age, co-morbidities, smoking habit, etc.) considered did 
not predict compliance levels. 
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INTRODUCTION 
The development of smartphones is relatively new phenomenon, but as 
smartphones become more and more popular in everyday life, they are being explored as 
tools to gather “real world data” on patients at a much greater frequency then the interval 
visits to a doctor’s office (Danaher et al., 2015). 
It wasn’t until the last decade that mobile health apps have become so prevalent 
(Heffner et al., 2015). As of 2015, there were over 100,000 mobile health apps available 
(Carroll et al., 2017). Types of health apps range from helping to regulate one’s food 
intake and exercise routine to assisting with mental health challenges (Nundy et al., 
2014). Mobile apps have since become a popular platform to develop health tools to 
affect behavior change partly due to their accessibility (Guo et al., 2017). People typically 
carry their mobile phones on a daily basis and often don’t leave home without it (Danaher 
et al., 2015). Many apps allow users to track any metric they desire and have it easily 
assessed by themselves or healthcare providers (Lam and Fresco, 2015)(Kanstrup et al., 
2018). Successful remote blood pressure monitoring programs for hypertension, diabetes 
management programs, and weight loss programs, among others have been developed 
and deployed (Kim et al., 2018). Being able to actively track, view, and change one’s 
health habits with the assistance of remote coaching provides a new model for behavioral 
modification (Baldwin et al., 2017)(Firth et al., 2016). 
Engagement on mobile health applications is a known challenge (Lee et al., 
2018). Multiple reports have described high early engagement with a dramatic drop-off 
after several weeks (Bahk et al., 2015). Despite the convenience of having the phone at 
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hand at all times, users may lose interest, grow frustrated, or fail to develop the habit of 
daily tracking (O’Connor et al., 2016). To combat the steep drop-off in engagement, 
applications have included goal setting features and community forums to increase the 
interaction with other users (Bardus et al., 2016)(Rana et al., 2016). Goal setting provides 
the user with a sense of accountability to thrive for the goal they set for themselves 
(Partridge and Redfern, 2018). Community forums have shown through social media 
platforms that mutual encouragement or friendly competition between peers that are 
working towards the same goal help drive individuals to stick to their plan and 
continuingly engage in the activity (Geng and Myneni, 2015)(Bahk et al., 2015). 
We developed and deployed a smartphone and smart watch-based activity 
tracking study to measure the repeatability and reliability of sensor data acquired in the 
clinic compared to the “real world” setting. This study required patients to perform an in-
clinic 6-Minute-Walk-Test (6MWT), which was then compared to Digital-6-Minute-
Walk-Tests (d6MWT) done at home. This study allows the scheduling of d6MWTs and 
participants were encouraged to take and record “Open Walks”. The devices also record 
daily passive data of the user’s activity throughout the day.  
For this master’s thesis we aimed to calculate engagement for patients in our 
study and also evaluate patient characteristics which were associated with both higher 
and lower engagement. 
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What is PAD, Aortic Valve Stenosis, and CAD? 
PAD stands for Peripheral Artery Disease. This disease refers to the narrowing of 
the arteries serving the leg, typically due to blockages from plaque build-up (Hiatt, 2001). 
The earliest symptoms experienced by patients with PAD include leg pain when walking, 
called claudication. Specifically, these pains are muscle pains or cramping in the legs that 
are triggered by what is believed to be the build-up of lactic acid due to anaerobic 
metabolism in leg muscles during activity (Qvarfordt et al., 1984). More advanced 
clinical presentation may include leg pain at rest from severe ischemia or non-healing 
wounds or gangrene (Hirsch et al., 2001). Risk factors for PAD include a smoking 
history, hypercholesterolemia, hypertension, advanced age (>65 years), and/or having a 
genetic predisposition (Criqui et al., 1992). PAD is first treated with optimal medical 
management (anti-platelet medication (aspirin), cholesterol lowering medication (statin), 
exercise) for mild to moderate disease in addition to surgical intervention for more 
advanced disease (Donnelly and Yeung, 2002). Surgical intervention could include 
angioplasty, where a balloon is temporarily inflated in the artery to open the blockage, 
with stent placement, as needed, to maintain and improve the blood flow (Hiatt, 2001). 
Aortic valve stenosis is characterized by calcification and subsequent narrowing 
of the aortic valve, which obstructs blood flow from the heart to the rest of the body 
(Stewart et al., 1997). Patients with this disease may experience symptoms of chest pain, 
fatigue, fainting, and/or shortness of breath (Amato et al., 2001). Along with those 
symptoms, the potential complications and worsening condition greatly reduce the 
quality of life of those individuals. Transcatheter Aortic Valve Replacement (TAVR) 
 4 
procedures is a novel endovascular surgical procedure that treats aortic valve stenosis by 
crushing the old valve with a stent and replacing it with a pig valve sewn onto the stent 
(Adams et al., 2014). TAVR is minimally invasive and is an option for individuals that 
cannot undergo open-heart surgery due to medical frailty (Leon et al., 2010). 
Coronary Artery Disease (CAD) describes atherosclerotic blockages in the 
arteries of the heart. Patients with this disease experience symptoms of chest pain and/or 
shortness of breath when doing light exercise (Redwood et al., 1972). CABG (Coronary 
Artery Bypass Graft) is a procedure that is commonly performed on patients who have 
CAD (Rocha, 2017). Other options besides CABG include coronary artery angioplasty or 
a stent placement. During CABG, a blood vessel harvested from elsewhere in the 
patient’s body is used to redirect blood flow in the heart muscles around the blocked area 
to re-establish blood flow and reduce symptoms and increase the quality of life (Kikuchi 
and Mori, 2017). 
 
The Study Itself 
“VascTrac” is a mobile app developed with the goals of being able to track 
walking activity levels in patients who have cardiovascular diseases. In this study, the 
patient population entails of individuals with peripheral arterial disease, coronary arterial 
disease, or aortic valve stenosis. The individuals are screened by a specific criterion 
during enrollment. Ideally, patients are recruited two weeks before their surgery and are 
followed in the study for six months. 
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Patients are identified as they come in for clinic visits at the hospital. Currently, 
all the patients participating in this ongoing study are veterans since the study recruits at 
the Palo Alto Veterans Affairs Hospital and the Livermore Veterans Affairs Hospital. 
Patients that come to the clinic normally exhibit symptoms of leg pain while walking, 
chest pain during activities, or shortness of breath upon exertion. In the case where 
patients are diagnosed with either peripheral arterial disease, coronary artery disease, or 
aortic valve stenosis and will potentially undergo surgery, the study is pitched to them by 
either a research coordinator or surgical staff. Patients are screened by the research 
coordinator. Below are the listed criteria: 
Table 1: Inclusion and Exclusion Criteria for Study Participation 
Inclusion Criteria Exclusion Criteria 
1) Are you scheduled for 
intervention/procedure for disabling 
claudication, tissue loss, or rest 
pain? 
2) Are you ambulatory (canes and 
walkers are permitted, scooters and 
wheelchairs are not)? 
3) Are you willing and able to operate 
a smartphone/watch 
4) Are you able to enroll two weeks 
prior to you 
intervention/procedure? 
 
1) Have you had a myocardial 
infarction in the past 30 days? 
2) Have you had chest pain at rest in 
the past 30 days? 
3) Do you have exercise limitation 
due to 
musculoskeletal/neurological 
disorder? (Arthritis, back pain, 
hip/knee pain, etc.) 
 
 
In order to be qualified for this study, patients need to be able to answer “yes” to 
all the inclusion criteria listed. There are some exceptions. In some cases, despite having 
one of the cardiovascular diseases described above, patients may not have their surgery 
scheduled yet. This still qualifies the patient for the study because they are most likely 
getting a surgery. If they do not, then they are grouped into the “control” group of the 
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study. Sometimes, patients are unable to enroll two weeks prior to their surgical 
procedure. In that case, as long as a pre-surgery state of their walking ability is collected 
through an in-clinic walk test, the patients will still have a baseline to compare to post-
surgery. Most of the patients do not know how to operate a smartphone or watch, but 
under the guidance of the clinical research coordinators and the patient’s own support 
group, they are trained to do so. 
Enrolling patients need to be able to answer “no” to all the listed exclusion 
criteria. There are some exceptions. Patients with unstable chest pain are prohibited from 
enrolling in the study. But if the chest pain is stable and patients are scheduled to receive 
intervention, they are able to enroll. We ask patients not to walk any farther than they 
normally would during the 6-Minute Walk Test. 
After the consent and screening, the first appointment for the d6MWT will be 
conducted. Before the actual walk, a consent form, contract, and a HIPAA form are 
signed by the enrolling patient. Patient responsibilities include not losing the phone and 
watch more than twice and doing weekly d6MWT unless excused. 
Demographic and other personalized information are also gathered from the 
patients. These includes the patient’s email address, prior cell phone information, primary 
support and caretaker’s information, their location and mode of transportation, frequency 
of Veterans Affairs Hospital visits, and their list of medications. Information about the 
type of smartphone they currently have, how long they have been operating smartphones, 
and how integrated their smartphone is in their life (how often they have it with them, 
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what they use their phone mostly for, and the types of applications used, etc) were 
collected during enrollment. This completes the one-time enrollment process. 
There are a total of three surveys completed during each visit on the “VascTrac” 
application: Medical Survey, Surgical Survey, and Walking Survey. 
The “Medical Survey” consists of questions that ask about the patient’s medical 
history and diagnoses. The first question asked is if the patient have been diagnosed with 
peripheral arterial disease, followed by questions about their last measured ABI 
(Ankle/Brachial Index) and TBI (Toe/Brachial Index). The survey also asks for whether 
or not the patient was diagnosed with diabetes, and if they are insulin dependent or on 
dialysis. A patient’s blood pressure and diagnosis of high blood pressure were also noted. 
Other questions include whether a patient has been diagnosed with coronary arterial 
disease, congestive heart failure, atrial fibrillation, and/or aortic valve. Smoking history 
and medications of the patient were also noted. 
The “Surgical Survey” consists of questions pertaining to surgical history. The 
three types of surgery of interest were intervention on the vasculature of the legs, 
intervention of the aortic valve, and intervention on the coronary arteries. The details 
such as the specific procedure, date, specific location, were recorded. 
The “Walking Survey” starts out by asking the patient about their leg pain and the 
conditions that surrounded the event. The patient’s shortness of breath and chest pain 
during daily activity is also inquired about. Other questions include asking if the patient 
has open wounds on his feet, preference for walking aids, involuntary weight loss, 
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experiences frailty, does daily physical activity, their ability to walk half a mile, walk up 
a flight of stairs, and do heavy work around the house. 
After the completion of the surveys, the d6MWT is conducted. An in-clinic 
d6MWT is a test that is performed within a six minute time frame. A chest strap is placed 
over the patient’s sternum to record the heart rate. A research coordinator will manually 
count the number of steps the patient takes throughout the whole walk. The patient walks 
on a pre-measured path to allow for the calculation of how far the patient was able to 
travel during this time. The patient’s motion is recorded on the phone and the watch via 
the accelerometers embedded in each device at 100Hz. Prior to each d6MWT, a brief 
survey will ask about current usage of walking aids and the current shortness of breath 
level. The patient will walk for six minutes as the research coordinator counts the number 
of steps and laps taken. When time is up, the patient is required to sit comfortably for 
three minutes and then answer some additional survey questions. These questions include 
their shortness of breath level, where the phone was kept during the walk, and whether or 
not the patient had recent injuries that may have impeded his walk. 
Patients are asked to return four more times to the hospital for additional in-clinic 
appointments with “VascTrac”. Ideally, the patients will be seen two weeks post surgery, 
one month post surgery, three months post surgery, and six months post surgery.  
At home, patients are asked to perform a d6MWT on a weekly basis. This will 
allow the patient to track their own progress through the app from pre to post surgery. 
During an at home d6MWT, patients are not required to wear a chest strap, nor are they 
required to walk a specific pre-measured route. 
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Patients are strongly encouraged to do “Open Walks” in addition to d6MWT. 
“Open Walks” are like d6MWTs, except they are not scheduled and there is no time 
limit. Once the patient starts the “Open Walk”, information will be continuously gathered 
until the patient stops walking or exit out of the “Open Walk”. A patient can choose to do 
as many or as little “Open Walks” he or she sees fit. 
At the end of the six months in the study, patients will have their last in-clinic 
d6MWT. After the d6MWT the patients will be asked to fill out the “End of Study 
Survey”, rating their satisfaction with the study and giving insight to their improvements 
throughout the study. This survey will help measure and determine the patient activation 
and is inspired by the “Patient Activation Measure”(Greene and Hibbard, 2012). The 
patients will be asked if they are interested in continuing participation. This entails the 
task of doing weekly at home d6MWT and “Open Walks” without the obligation of doing 
in-clinic d6MWT. 
Some patients are selected based on their compliance data for an in person or 
over-the-phone interview. See Appendix I and II for “End or Study” survey and interview 
questions. 
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METHODS 
This thesis focuses on one aspect of the study - patient compliance. In order to 
measure that, two important metrics were recorded: at home d6MWT and “Open Walks.” 
A d6MWT is performed at home on a weekly basis. Patients will get a 
notification once a week that prompts them to do their d6MWT. Once the notification is 
sent in the morning, patients have the rest of the day until midnight to complete the 
d6MWT in order for it to be considered on time. The d6MWT option will remain active 
until the patient does the d6MWT or the following week’s d6MWT is sent. If the patient 
completes the d6MWT within the week, the d6MWT will be considered completed. 
At home d6MWT compliance percentage is calculated as the number of 
completed walks over the number of total at home walks that should have been 
completed. The maximum number of at home d6MWT a patient can do during the study 
is 28 walks. There are two walks completed prior to the surgery and 26 walks (six months 
total) completed after intervention. Some patients will only be part way through the study 
at the time this data is collected and therefore would have a smaller number of total 
possible d6MWTs.  
𝐶𝑜𝑚𝑝𝑙𝑖𝑎𝑛𝑐𝑒 = 𝑁𝑢𝑚𝑏𝑒𝑟	𝑜𝑓	𝑡𝑜𝑡𝑎𝑙	𝑑6𝑀𝑊𝑇𝑠	𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒𝑑	𝑏𝑦	𝑡ℎ𝑒	𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑁𝑢𝑚𝑏𝑒𝑟	𝑜𝑓	𝑡𝑜𝑡𝑎𝑙	𝑝𝑜𝑠𝑠𝑖𝑏𝑙𝑒	𝑑6𝑀𝑊𝑇𝑠	𝑡ℎ𝑒	𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑐𝑜𝑢𝑙𝑑	𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒 
Patients have the option to activate an “Open Walk” if there are no pending 
d6MWTs that needs to be done. The number of “Open Walk” a patient can do is 
unlimited. “Open Walks” are totaled up for each patient. The average amount of “Open 
Walks” per week is calculated and is dependent on how long a patient has been 
participating in the study. 
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𝐴𝑣𝑒𝑟𝑎𝑔𝑒	“𝑂𝑝𝑒𝑛	𝑊𝑎𝑙𝑘”	𝑝𝑒𝑟	𝑊𝑒𝑒𝑘 = 𝑇𝑜𝑡𝑎𝑙	𝑛𝑢𝑚𝑏𝑒𝑟	𝑜𝑓	“𝑂𝑝𝑒𝑛	𝑊𝑎𝑙𝑘𝑠”𝑇𝑜𝑡𝑎𝑙	𝑛𝑢𝑚𝑏𝑒𝑟	𝑜𝑓	𝑤𝑒𝑒𝑘𝑠	𝑖𝑛	𝑠𝑡𝑢𝑑𝑦. 
Using the data from the surveys and information supplied during the enrollment 
appointment, a database for each patient was created. Survey results from before and 
after their surgery were taken into consideration, if applicable. Some patients will have 
missing data points because they had not had their surgery at this point, or will not be 
undergoing surgery. 
There are four categories that a patient could fall under: peripheral arterial 
disease, Coronary Artery Bypass Graft (for patients diagnosed with CAD), Transcatheter 
Aortic Valve Replacement (for patients diagnosed with aortic valve stenosis), and 
control. Basic background information such as age, support system at home, prior phone 
usage, type of phone, distance from the hospital, and transportation mode were recorded. 
Answers may vary each time the patient takes the survey during an in clinic 
d6MWT. To extract a single value from the variable survey answers, the answers are 
tallied and the answer that is most commonly provided by the patient will be taken into 
consideration. The answers from before and after the surgery were analyzed separately 
but in the same manner. For example, if a patient answers a survey four times after their 
surgery, where one answer shows up three times and the other answer shows up once, the 
answer that appeared three times will be taken into consideration. Each patient is taken 
on a case by case basis and answers are cross checked for validity with the clinical 
research coordinators and electronic medical records. The types of questions asked 
included whether a patient experiences leg pain during walking, shortness of breath upon 
exertion, and chest pain during activity before and/or after the surgery. Patients are asked 
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whether they feel that simple tasks take extra effort to ‘get started on’ and are also asked 
about their activity level, both before and after the surgery, if applicable. 
Other questions that should not vary too much within the six months of the study 
included whether or not the patient had been diagnosed with diabetes, hypertension, 
congestive heart failure, and atrial fibrillation. Patients are also asked if they are either a 
current smoker, a former smoker, or if they have never smoked before. 
After the data was collected and organized for each individual, the participants 
were split into four different groups. Sixty-six (66) participants were enrolled at the time 
the study data was collected. Patients were categorized into four groups, 0-25% 
compliance (Group A), 25.1-50% compliance (Group B), 50.1-75% compliance (Group 
C), and 75.1-100% compliance (Group D).  
Within each group of patients, similarities and trends will be identified. The 
factors that each group was analyzed on includes, 1) surgical procedure performed, 2) 
participation in “Open Walks”, and 3) the average rate of “Open Walks”. Factors related 
to patient’s background includes age, presence of caretakers and support at home, phone 
usage prior to joining study, type of phone, distance to the VA, and availability of 
reliable/independent transportation. The health-related factors include leg pain, shortness 
of breath, chest pain, walking aid, daily exertion of effort to ‘get going’, physical activity 
lever, and diagnosis of diabetes, hypertension, congestive heart failure, atrial fibrillation, 
and smoking history. With “End of Study Survey” results and interview answers, 
individual cases were studied from each group to better understand the reasoning behind 
their compliance to the app and study.  
 13 
RESULTS 
Characterization of the Patient Population 
In this study, there were a total of 66 unique participants enrolled. Of the 66 
patients, all of the participants in the study are male due to the prevalent population that 
seek medical attention from the Veterans Affair Hospital being males. The average age of 
the participants is 68.2 years of age, with the median of 68 years and a standard deviation 
of 6.0 years. In Figure 1, a distribution of the patients ages is visualized. 
 
Figure 1: Ages of Patients Participating in VascTrac Study 
 
The patient population could be categorized into four different groups dependent 
on the surgical procedure or diagnosis of each individual. The four different groups 
include, 1) PAD patients, 2) CABG patients, 3) TAVR patients, and 4) control patients 
who would not have surgery during participation in the study. Figure 2 shows the number 
of patients that fall into each category. 
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Figure 2: Distribution of Surgical Procedures or Diagnosis of Population 
 
There are 33 PAD patients (50% of the population), 12 CABG patients (18.2% of 
the population), 8 TAVR patients (12.1% of the population), and 13 control patients 
(19.7% of the population). 
Other diagnoses that were surveyed in addition to PAD, aortic valve stenosis, and 
CAD includes diabetes, hypertension, congestive heart failure, and atrial fibrillation. 
Figure 3 shows how many patients were diagnosed with the disease mentioned. 
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Figure 3: Additional Diseases Diagnosed in Patient Population 
 
A total of 22 patients have diabetes, total of 51 patients have hypertension, total of 
6 patients have congestive heart failure, and a total of 11 patients have atrial fibrillation. 
Many of these patients have been diagnosed with more than one disease with the 
combination of diabetes and hypertension as the most common. 
The patient population was also analyzed for smoking habits. Fourteen (14) 
patients are currently smoking, 45 patients are former smokers, and 7 patients have never 
smoked before. In sum, 89.4% of the patients were either current or prior smokers. Figure 
4 represents the distribution of smoking habits. 
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Figure 4: Smoking Habits in Patient Population 
In the population studied, a small group of patients that use walking aids for the 
majority of the time, such as a cane, walker, or wheelchair. The other patients do not 
require walking aids. In Figure 5, 12 patients use canes, 5 patients use walkers, 2 patients 
use wheelchairs, and 47 patients do not use any walking aids for the majority of their 
time. 
 
Figure 5: Walking Aids Used by Patients 
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Below is Figure 6 that represents the number of patients in each distance-from-
the-VA bracket. Distance was calculated based on which VA (Palo Alto or Livermore) 
the patient goes to and rounded to the nearest integer. A total of 20 patients travel less 
than 25 miles to get to the VA, 18 patients travel 26-50 miles, 24 patients travel 51-100 
miles, and 4 patients travel over 100 miles to get to the VA. 
 
Figure 6: Distance Patients Travel to the VA Hospital 
 
The type of phones prior to switching over to the study’s iPhone is recorded for 
each patient. As seen in Figure 7, prior to the study, 14 patients used Androids, 25 
patients used iPhones, 16 patients used a type of non-smart phone, and 9 patients did not 
specify which type of phone they used. 
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Figure 7: Types of Phone used in Patient Population 
 
Compliance Results 
Within all 66 patients in the study at this time, the patient’s at home d6MWT 
compliance average is 66.1%. As seen in Figure 8, the distribution of patient compliance 
skews towards the higher, more compliant side of the scale. The mode is 100% 
compliant, the median is 80% compliant, and the standard deviation is 32.7%. 
Compliance level was also observed to see if it increased after the first month where the 
patients gets used to the iPhone. In the first month enrolled in the study, the average 
compliance level is 67.2%. The compliance level after the first month is 61.5% (p-value 
= 0.3). Only patients (64 total) that were in the study for more than one month was 
considered in this calculation. 
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Figure 8: Patient Compliance 
Figure 9 depicts number of at home d6MWT performed by each patient as of Jan. 
6th, 2019. 
 
Figure 9: Number of Total d6MWT per Patient 
Optional “Open Walks” done by each patient is illustrated in Figure 10a and 
Figure 10b. Due to one patient, patient 13, having significantly more “Open Walks” 
completed, Figure 10b did not include patient 13 and provides a more detailed view of 
the number of “Open Walks” completed by others. 
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Figure 10: a) Total number of Open Walks Completed by each Patient; b) Total 
number of Open Walks Completed by each Patient with Patient 13 removed 
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To better understand the completion rate of “Open Walks” for each patient, a 
weekly average is calculated. The weekly average amongst patients is 0.53 “Open 
Walks” per week. Figure 11 depicts the weekly average for each participating patient. 
 
Figure 11: Open Walk Weekly Average for Each Patient 
 
The relationship between doing d6MWT and “Open Walks” is graphed in Figure 
12. There is a positive correlation (correlation coefficient = 0.3) between the number of 
“Open Walks” done and the compliance rate of the patient.  
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Figure 12: Average Open Walk per Week versus d6MWT Compliance Level 
 
Compliance Groups 
In order to evaluate the relationship of compliance and a multitude of factors, the 
patient population is split into four groups. Group A consist of patients with compliance 
levels of 0-25%, Group B consist of patients with compliance levels of 25.1-50%, Group 
C consist of patients with compliance levels of 50.1-75%, and Group D consists of 
patients with compliance levels of 75.1-100%. Figure 13a provides a visualization of the 
portion of patients in each group. 
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Figure 13: Patient Group Distribution Based on Compliance a) top; b) bottom 
 
Figure 13b states 9 patients belong to Group A, 13 patients belong to Group B, 8 
patients belong to Group C, and 36 patients belong to Group D. 
 
Characterization of Compliance Groups 
Each group have patients with different ages as seen in Figure 14. Numbers 
represent the number of patients that falls in a given age range in a certain group. 
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Figure 14: Age Distribution Between Groups 
 
The average “Open Walks” per week rate for each group is listed in Table 2 
Table 2: Average Number of Open Walks/Week in Each Group 
Group Average Number of Open 
Walks/Week 
A 0.035 open walks/week 
B 0.568 open walks/week 
C 0.26 open walks/week 
D 1.16 open walks/week 
 
The additional comorbidities of diabetes, hypertension, congestive heart failure, 
and atrial fibrillation is depicted in Figure 15. Group A has 3 diagnosis of diabetes, 8 
diagnosis of hypertension, 0 diagnosis of congestive heart failure, and 3 diagnosis of 
atrial fibrillation. Group B has 4 diagnosis of diabetes, 11 diagnosis of hypertension, 1 
diagnosis of congestive heart failure, and 2 diagnosis of atrial fibrillation. Group C has 3 
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diagnosis of diabetes, 7 diagnosis of hypertension, 1 diagnosis of congestive heart failure, 
and 2 diagnosis of atrial fibrillation. Group D has 12 diagnosis of diabetes, 25 diagnosis 
of hypertension, 4 diagnosis of congestive heart failure, and 4 diagnosis of atrial 
fibrillation. Patients could be diagnosed with multiple problems. 
 
Figure 15: Additional Diagnoses of Patients in Each Group 
 
Smoking is characterized between groups in Figure 16. In Group A, 3 individuals 
identified as a current smoker, 4 identified as a former smoker, and 2 individuals had 
never smoked before. In Group B, 2 individuals identified as a current smoker, 11 
identified as a former smoker, and 0 individuals had never smoked before. In Group C, 3 
individuals identified as a current smoker, 5 identified as a former smoker, and 0 
individuals had never smoked before. In Group D, 6 individuals identified as a current 
smoker, 25 identified as a former smoker, and 5 individuals had never smoked before. 
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Figure 16: Smoking Habits Between Groups 
 
Figure 17 shows whether or not the patient states usage of walking aids for the 
majority of the time. Group A consists of 5 (55.5%) patients that uses walking aids, and 4 
patients that does not. Group B consists of 7 (53.8%) patients that uses walking aids, and 
6 patients that does not. Group C consists of 3 (37.5%) patients that uses walking aids, 
and 5 patients that does not. Group D consists of 4 (11.1%) patients that uses walking 
aids, and 32 patients that does not. 
 
Figure 17: Usage of Walking Aids Between Groups 
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Patient transportation goes hand-in-hand with the support system the patients have 
at their own homes. Support system at home normally provides patient with flexible and 
reliable transportation method to the VA Hospital. In Figure 18, a representation of how 
many patients have independent, reliable versus dependent, unreliable transportation is 
shown. 
 
Figure 18: Patients Transportation Type Between Groups 
 
The average distance traveled in each group is as noted in Table 3. 
Table 3: Average Distance Traveled in Each Group 
Group Average distance traveled to get to the Hospital in miles 
A 53.67 miles 
B 57.15 miles 
C 49.125 miles 
D 43.64 miles 
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The type of phones each individual in each Group had before signing up for the 
study is noted in Figure 19. In Group A, 1 patient used an Android, 4 used iPhones, 4 
used non-smartphones, and none of them did not specify the type of phone they used 
prior to the study. In Group B, 4 patients used an Android, 7 used iPhones, 1 used non-
smartphones, and 1 did not specify the type of phone they used prior to the study. In 
Group C, 1 patient used an Android, 3 used iPhones, 1 used non-smartphones, and 3 did 
not specify the type of phone they used prior to the study. In Group D, 8 patients used an 
Android, 11 used iPhones, 10 used non-smartphones, and 7 patients did not specify the 
type of phone they used prior to the study.  
 
Figure 19: Patient’s Prior Phone Type Between Groups Before Enrollment 
 
In the next two figures, Figure 20 provides a visual representation of how much 
effort it took for patients to ‘get going’ and Figure 21 shows whether a patient is active or 
sedentary. In Group A, 22.2% of the group states they find everyday actions to require a 
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lot of effort. In Group B, 61.5% does, in Group C, 50% does, and in Group D, 25% of the 
patients find it effortful to ‘get going’. 
 
Figure 20: Patients by Group on Everyday Effort to Get Going 
 
In Group A 11.1% of the patients is active; in Group B 30.8% are active, in Group 
C 37.5% are active, and in Group D, 22.2% of the patient population state that they lead 
an active lifestyle. 
 
Figure 21: Patients by Group on Physical Activity Level 
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Changes in Symptoms from Before Surgery to After Surgery 
The three main symptoms that are reported in this study are leg pains, chest pain, 
and/or shortness of breath. As seen in Figure 22, of the 66 patients, a total of 58 patients 
display at least one of the symptoms. In Group A, a total of 8 people (88.9%) have at 
least one of the listed symptoms. In Group B, a total of 11 people (84.6%) fall in that 
category. In Group C, 8 people (100%) are affected by at least one symptom. And in 
Group D, 31 patients (86.1%) are affected. 
 
Figure 22: Patients Affected by at Least One Symptom 
 
Leg Pain 
In the Figure 23, the presence of leg pain is evaluated and graphed for each group 
of patients before and after the surgery. This data was gathered during the in-clinic 
d6MWT surveys. There is a trend of improvement after the surgery in each group where 
more patients state ‘No Leg Pain’ in comparison to before the surgery. In Group A, the 
percent of people who had no leg pain went from 55.6% to 100%; in Group B, the 
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percentage went from 53.8% to 70%; in Group C it went from 25% to 75%, and in Group 
D the percentage increased from 27.3% to 70%. 
 
Figure 23: Pre-Surgery and Post-Surgery Leg Pain in Patients 
 
In Table 4, the number of patients that falls within each category is listed. Patients 
categorized under “N/A” did not have pre-surgical or post-surgical data and were 
excluded from the calculation. The net improvement rate in patients from having leg pain 
to not having leg pain is positive in all four Groups. Over all groups, 63.5% of the 
patients had leg pain before the surgery, and after the surgery, 24.4% had leg pain (p-
value = 0.013). 
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Table 4: Leg Pain in Patients Before and After Surgery  
 Pre-Surgery Post-Surgery No. Pt 
Improved 
No. 
Patient 
that 
Worsen 
Compliance 
Group 
Leg 
Pain 
No 
Leg 
Pain 
N/A % w/ 
Leg 
Pain 
Leg 
Pain 
No 
Leg 
Pain 
N/A % w/ 
Leg 
Pain 
Group A 4 5 0 44.4% 0 7 3 0% 3 0 
Group B 6 7 0 46.2% 3 7 3 30% 2 1 
Group C 6 2 0 75% 1 3 4 25% 2 0 
Group D 24 9 3 72.7% 6 14 15 30% 8 0 
 
Chest Pain 
Improvement in chest pain after surgery is detected in three of the four groups. In 
Group A, the improvement increased from 66.7% to 100%, in Group B improvement 
increased from 84.6% to 100%, in Group D, improvement increased from 84.8% to 
95.2%. Patients in Group C did not have chest pain before or after surgery. 
 
Figure 24: Pre-Surgery and Post-Surgery Chest Pain in Patients 
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In Table 5, the exact number of patients that fall within each category is listed. 
There is a net positive in patients that do not experience chest pain after the surgery. Over 
all groups, 15.9% of the patients had chest pain before the surgery, and after the surgery, 
2.3% had chest pain (p-value = 0.117). 
Table 5: Chest Pain in Patients Before and After Surgery 
 Pre-Surgery Post-Surgery No. Pt 
Improved 
No. 
Patient 
that 
Worsen 
Compliance 
Group 
Chest 
Pain 
No 
Chest 
Pain 
N/A % w/ 
Chest 
Pain 
Chest 
Pain 
No 
Chest 
Pain 
N/A % w/ 
Chest 
Pain 
Group A 3 6 0 33.3% 0 7 2 0% 1 0 
Group B 2 11 0 15.4% 0 11 2 0% 1 0 
Group C 0 8 0 0% 0 4 4 0% 0 0 
Group D 5 28 3 15.2% 1 20 15 4.8% 2 0 
 
Shortness of Breath 
Figure 25 provides a visualization of patients with shortness of breath before and 
after the surgery. There are improvements after the surgery in every group of patients 
where less patients experience shortness of breath. In Group A, the percentage of patients 
without shortness of breath increased from 55.6% to 83.8% after surgery. In Group B, the 
percentage increased from 30.8% to 50%, in Group C, 12.5% to 50%, and in Group D, 
51.5 to 60%. 
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Figure 25: Pre-Surgery and Post-Surgery Shortness of Breath in Patients 
 
Table 6 states the number of patients in each SOB category. Over all groups, 
57.14% of the patients experience shortness of breath before the surgery, and after the 
surgery, 40.0% experience shortness of breath upon exertion (p-value = 0.120). 
Table 6: Shortness of Breath in Patients Before and After Surgery 
 Pre-Surgery Post-Surgery No. Pt 
Improved 
No. 
Patient 
that 
Worsen 
Compliance 
Group 
SOB No 
SOB 
N/A % w/ 
SOB 
SOB No 
SOB 
N/A % w/ 
SOB 
Group A 4 5 0 44.4% 1 5 3 16.7% 1 0 
Group B 9 4 0 69.2% 5 5 3 50% 3 1 
Group C 7 1 0 87.5% 2 2 4 50% 2 1 
Group D 16 17 3 48.5% 8 12 15 40% 3 0 
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Ability to Walk Half a Mile 
A metric used to measure patient physical activity level is whether or not they are 
able to walk half a mile before and/or after the surgery. In Figure 26, Group B, C, and D 
all experienced improvements post-surgery, while Group A did not. The percentage of 
patients that could walk half a mile in Group A decreased from 55.6% to 16.7% after the 
surgery. Group B increased from 50% to 60%, Group C increased from 37.5% to 50%, 
and Group D increased from 54.5% to 71.4% after the surgery. 
 
Figure 26: Pre-Surgery and Post-Surgery Ability of Patients to Walk Half a Mile 
 
In Table 7, the number of patients that could or could not walk half a mile before 
and/or after the surgery are listed. In Group B, C, and D, there is a net positive in an 
increase of physical ability to walk half a mile after surgery, but in Group A, there is a net 
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decrease where more patients couldn’t walk half a mile after the surgery – this could be 
why their walking compliance decreased, because of complications or intervention or 
worsening medical condition. Over all groups, 47.7% of the patients could not walk half 
a mile before the surgery, and after the surgery, 41.5% of the patients were not able to 
walk half a mile (p-value = 0.902). 
Table 7: Patient’s Ability to Walk Half a Mile Before and After Surgery 
 Pre-Surgery Post-Surgery No. Pt 
Improved 
No. 
Patient 
that 
Worsen 
Compliance 
Group 
Can’t 
Walk 
Can 
Walk 
N/A % that 
Can’t 
Walk 
Can’t 
Walk 
Can 
Walk 
N/A % that 
Can’t 
Walk 
Group A 4 5 0 44.4% 5 1 3 83.3% 1 3 
Group B 7 7 0 50% 4 6 3 40% 3 1 
Group C 5 4 0 55.6% 2 2 4 50% 2 1 
Group D 15 18 3 45.5% 6 15 17 28.6% 6 3 
 
Ability to Climb a Flight of Stairs 
In addition to walking half a mile, stair climbing was also used as a metric to see 
if there were changes in patient’s physical ability level. There is no obvious trend that 
shows whether or not patients will be able to climb stairs after their surgeries. In Group A 
and B, there is a decrease, and in Group C and D, there is an increase in percentage of 
people who can climb stairs after their surgeries. Group A decreased from 77.8% to 
33.3% and Group B decreased from 84.6% to 80%. In the case of Group C, the 
percentage of patients that experienced an improvement in stair climbing ability went 
from 75% to 100% and in Group D went from 84.8% to 95%. 
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Figure 27: Pre-Surgery and Post-Surgery Ability of Patients to Climb Stairs 
 
Table 8 shows a net negative in patients that can climb stairs in Group A, a net of 
zero in group B, and a net positive in Group C and D. Over all groups, 17.5% of the 
patients could not climb up a flight of stairs before the surgery, and after the surgery, the 
same percentage of the patients were able to climb up a flight of stairs (p-value = 0.835). 
Table 8: Patient’s Ability to Climb Stairs Before and After Surgery 
 Pre-Surgery Post-Surgery No. Pt 
Improved 
No. 
Patient 
that 
Worsen 
Compliance 
Group 
Can’t 
Climb 
Can 
Climb 
N/A % that 
Can’t 
Climb 
Can’t 
Climb 
Can 
Climb 
N/A % that 
Can’t 
Climb 
Group A 2 7 0 22.2% 4 2 3 66.7% 1 3 
Group B 2 11 0 15.4% 2 8 3 20% 1 1 
Group C 2 6 0 25% 0 4 4 0% 1 0 
Group D 5 28 3 15.2% 1 19 15 5% 2 0 
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End of the Study Survey 
At the end of the study, patients fill out a survey. At the time this data was 
collected, there were a total of 14 participants that had finished the study and provided 
feedback. The values for the first four questions are scaled from ‘1’ being “not very” to 
‘5’ being “very much”. 
From the first two questions in the survey regarding comfort level with the 
smartphone and watch, there was an increase in the average comfort level from 3.8 
(standard deviation of 1.4) to 4.4 (standard deviation of 0.7) out of 5. Figure 28 and 
Figure 29 shows the distribution of the answer’s given. The median for comfort level 
before enrolling is 4, and the median after completion of the study is 5. 
 
Figure 28: “End of Study Survey” Question One Results 
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Figure 29: “End of Study Survey” Question Two Results 
 
In the third and fourth questions, patients are asked to provide a self-reflective 
answer when it comes to their activity level from before enrollment versus their activity 
level at the end of the study. On average, the rated activity level was 3.1 (standard 
deviation 1.6) before enrollment and increased to 3.7 (standard deviation 1.1) after the 
study. The median for before and after the study is 3 and 4, respectively. Figure 30 and 
Figure 31 shows the patients responses. 
  
Figure 30: “End of Study Survey” Question Three Results 
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Figure 31: “End of Study Survey” Question Four Results 
 
For questions five to seven, answer options are provided on a 5-point scale where 
‘1’ is “strongly disagree” to ‘5’ is “strongly agree”. These answers provide insight on the 
level of activation the patient feels towards working on their own health outcome. For 
question 5, the average is 4.2 (standard deviation of 0.9) out of 5, and with a median of 4. 
For question 6, the average is 4 (standard deviation of 0.9) out of 5, and with a median of 
4. For question 7, the average is 3.5 (standard deviation of 1) out of 5, and with a median 
of 3. 
 
Figure 32: “End of Study Survey” Question Five Results 
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Figure 33: “End of Study Survey” Question Six Results 
 
Figure 34: “End of Study Survey” Question Seven Results 
 
Next, the willingness of patients to continue their walking habit after the study is 
asked in the next question (Figure 35). From this chart, 92.9% of the 14 patients are 
interested in continuing the lifestyle they developed during the study. 
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Figure 35: “End of Study Survey” Question Regarding Interest in d6MWT 
Continuation 
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DISCUSSION 
The average compliance of the weekly at home d6MWT amongst all 66 
participants was 66.1% as of January 6th, 2019. However, half of the patients scored over 
80% in compliance to weekly d6MWT. The average was brought down by seven patients 
who have compliance level below 10%, five of those being at 0%. There was not a 
significant difference in compliance levels observed between the first month of 
enrollment versus the remaining time the participant was in the study. It can be argued 
that although some patients have increased compliance after the first month due to 
becoming more familiar with the technology, other patients have decreased compliance 
due to health issues and decreased motivation. 
During the exit interviews of participants a few common problems were 
described. First time iPhone users reported technical difficulties. It proved challenging to 
teach smartphone naive patients how to operate a smartphone, but once they got familiar 
with it, technical difficulties became less of an issue for patients when doing their weekly 
d6MWT. The most common reasons for poor weekly d6MWT compliance were medical 
events (illness/hospitalization) or inability to achieve technical mastery. Throughout the 
study, some patients became ill and were be unable to perform the d6MWT. Some 
examples include an extended stay at the ICU after a procedure requiring hospitalization 
or pneumonia. Other patients experience is limited by other conditions which limit their 
ability to walk, such as hip, knee or back pain. These ankle, knee, hip, or back pains 
make walking and doing the d6MWT a challenge that is hard to physically overcome. 
There is also an added mental factor when it comes to doing weekly d6MWTs. One 
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patient, during his interview, said that he has a hard time finding the motivation to start 
doing the d6MWT because he knows walking will trigger pains in his legs. When asked 
why he did not stop when he started to feel pain, he stated that he was not weak and did 
not want to be seen as weak by others in public. Despite stating that he thinks about 
quitting halfway through his walk, his stubborn personality and motivation pushes him to 
finish the d6MWT. Other patients may not have the same drive as the patient previously 
mentioned and may choose to skip their weekly d6MWT. 
On the other hand, patients who were more compliant and did their weekly 
d6MWT find reasons to keep themselves motivated. A common reason was that the 
patient is interested in self-improvement. Having the ability to track everything provides 
a track record of how they’re doing, which a lot of times proved to be gratifying. One 
patient gamifies the task where he tries to reach a specific goal every day. Another patient 
was motivated by wanting to simply help future patients who may use the app and also by 
knowing the “VascTrac” team is interested in his welfare. A desire for an active lifestyle 
and better health was another patient’s reason to stay motivated and complete d6MWT. 
This same patient stated that he would like to start hiking and doing sports again. Another 
patient was motivated by the idea of being able to prove people wrong because they did 
not believe his health was going to get better; he did not want to be categorized as “sick” 
by others. 
The relationship between being compliant to weekly at home “6 Minute Walk 
Test” (d6MWT) and “Open Walk” could be considered to be slight positive correlation 
(correlation coefficient = 0.3). Only individuals found in the 75.1% and more compliance 
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range (Group D) do more than twice the amount of “Open Walks” than individuals below 
the 75% compliance threshold. This could be due to some individuals that already 
dedicate their time to doing d6MWT are looking for additional avenues to improve their 
health; they will not restrict themselves from tracking just one walk per week. On the 
other hand, about half of the patients who fall in the 75.1% and higher compliance range 
and does not do as many “Open Walks” as their peers in the same range. This could be 
due to pain felt during walking, but the patients still pushed themselves to do at least the 
bare minimum and so achieved a high d6MWT compliance. Another reason may be that 
upon enrollment, the research coordinator did not encourage or emphasize to the patient 
to do “Open Walks” leaving the patient to believe that these optional “Open Walks” are 
insignificant. 
The population of the study was split into 4 groups to further evaluate factors that 
differ between the groups and may cause different compliance rates to d6MWT. As 
previously noted, the largest group is Group D which consists of over half of the 
participants. This group has the highest compliance percentage and proves that for the 
most part, the study was executed in a manner where patients understood and were 
willing to commit to the program. When examining ‘Age’, there was not a noticeable age 
or age range that tended to be more or less compliant. Compliance outcome was also not 
predictable based on what type of disease the patient is dealing with; from PAD, CAD, 
aortic valve stenosis, to diabetes, hypertension, congestive heart failure and atrial 
fibrillation. In fact, each group has a similar percentage of patients that were either 
diagnosed with diabetes or hypertension. This suggests that hypertension and diabetes do 
 46 
not contribute to differences in patient compliance. As for smoking habits, there are more 
patients that ‘never smoked’ within Group D, but no other conclusion could be drawn 
from smoking habits with respect to compliance. Independent transportation provides 
flexibility where patients can come and go as they pleased without having to worry about 
catching public transportation or relying on unpredictable resources for rides. When it 
comes to having reliable, independent transportation, compliance is not affected. Having 
reliable, independent transportation will likely affect in-clinic appointments as opposed to 
at home weekly d6MWT that does not require the patient to leave their house. Most 
patients live within 100 miles of their respective VA Hospital (Palo Alto or Livermore), 
but this again does not affect compliance because patients are not required to come into 
the hospital for their at home d6MWT in order to be compliant. 
There were some factors that did affect compliance. For instance, patients that do 
not need walking aids to help walk tend to exhibit higher compliance. Not using walking 
aids implies that a patient does not have as much difficulty walking around and therefore 
the ‘pain’ factor does not exist as much to discourage them from walking. Technical 
difficulties were a barrier for over half of the patients, so in the case where the patient is 
switching over from a non-smartphone, there tends to be a lower compliance level 
observed. Another finding was that patients who find it effortless to ‘get going’ on the 
daily basis and lead a relatively active lifestyle tends to be more compliant. This 
phenomenon could be explained by the baseline capability of the patients to do walks that 
puts them in a better position in terms of effort and activity. With an active lifestyle, 
patients are more likely to be motivated to stay healthy and may experience fewer 
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inhibiting pains, and therefore endure d6MWTs to stay active. In some cases, patients 
may be highly motivated but display low compliance. After interviewing these patients, 
the reason for the low compliance was due to health issues such as extended stays in the 
ICU after surgery or other complications that prevented them from performing walks. 
Undergoing surgery has proven to be beneficial to patients in multiple areas. 
These patient’s improvements did not vary with compliance rate. For example, symptoms 
such as leg pain, chest pain, and shortness of breath improved after surgery for all groups. 
Out of the three, only leg pain improvement post-surgery was statistically significant. 
There are some cases where patients experience the opposite, but on a whole, there is a 
net positive outcome that supports the advantage of having surgery. When it comes to 
metrics based on activity, there was not a clear outcome of whether surgery helped or not. 
For instance, when patients within the groups are asked if they could walk half a mile, 
improvements were observed in Groups B, C, and D, but not A. Group A consists of 
patients with low compliance. A reason that improvement was not observed in this group 
could be explained by sedentary lifestyle that many individuals in this groups lead. Such 
habits are not fixable by surgery. As for the ability to climb up a flight of stairs, Group C 
and D showed improvement post surgery. For Group B, there is a slight increase of 4.6% 
of patients that experience difficulty with climbing stairs post surgery. But in Group A, a 
higher increase of 44.5% was observed post surgery for patients that are unable to climb 
stairs. Patients in Group A use and need more walking aids for the majority of their time 
than other groups, because these patients may have a harder time ambulating around. 
Some walking aids are inherently hard to use on staircases, such as walkers and 
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wheelchairs, which will inhibit patients from climbing up a flight of stairs. In cases where 
a patient’s physical ability of walking half a mile or up stairs does not improve with 
surgery, there is a possibility that these patients had slow recovery rates or encountered 
complications. 
There were a total of 14 participants that completed the study when this data was 
collected. From the survey results, it can be inferred that from using the smart phone and 
watch for 6 months, patients became more comfortable with these devices and with 
tracking their walking. Due to increased familiarity to the devices and application, 
patients are able to actively engage with their health by tracking their progress through 
the weekly walks. This leads to an increased “activation” where patients became more 
active and felt more knowledgeable about their own health conditions and become more 
motivated to engage in a healthier lifestyle. Nearly ninety-three percent (92.9%) of 
finishing patients agreed to continue tracking their walks which indicates a proactive 
attitude in maintaining their new lifestyle they developed during this study. 
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LIMITATIONS  
There are several notable limitations to this study at this time. First, at the time the data 
was extracted, there were 66 patients that were part of the study and only 14 of which had 
completed it. Having more patients enrolled and more data could potentially uncover 
other factors that affect compliance rates. Within the data extracted, there were also some 
data points that were missing. In some cases, it is because a patient had not yet undergone 
surgery and therefore would not have post-surgery results. Some of the other missing data 
could be attributed to patients being unable to provide the research coordinator with it. 
There is also bias when it comes to having multiple research coordinators. Having 
different research coordinators that enrolled different patients could lead to minor 
inconsistencies in the information and instructions provided to the patients. With 
differing encounters, patients may experience confusion with the app if the research 
coordinator fails to explain it clearly. Patients may also choose to be less actively 
involved in the study compared to other subjects if the importance of the walks were 
emphasized differently. 
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CONCLUSION  
 Patient compliance to performing weekly d6MWT was 66.1% for all participants 
with half of the participants scoring 80% and above. Factors that negatively affect 
whether or not patients would be compliant to doing the weekly d6MWT are medical 
issues, technical difficulties, hospitalization, and lack of motivation. Being motivated and 
having a desire for self-improvement positively influences compliance levels. Reliance 
on walking aids lowered compliance, as did a history of being smartphone naïve.  
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APPENDIX I 
End of Study Survey: 
1) How comfortable were you with using a smartphone and watch prior to enrolling 
in the study? 
2) How comfortable are you now with using the smart phone and watch? 
3) How active were you prior to enrolling in the study? 
4) How active are you now? 
5) I am knowledgeable about my health condition(s) and know what I can do to 
improve my health, 
6) I have made changes in my lifestyle that would improve my health condition or 
prevent further problems. 
7) I am confident that I can maintain healthy lifestyle choices like diet and exercise. 
8) Additional comments & feedback. 
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APPENDIX II 
Patient Interview Questions and Answers 
 
Patient 1 
1) What motivated you to walk? 
 I wanted to know how well and quickly I was getting better and they asked me to. 
2) Did it feel like a chore when you received the notification to do the WT? 
 No, not at all. 
3) What kept you from doing the scheduled walk if you missed out on a week or so? 
Usually something like it was raining or I didn't want to go out. And finding 
motivation... I tried to make up for it the next day. 
4) What kept you from doing Open Walks if applicable? 
 Motivation level 
5) How do you feel after/during each WT? 
I felt fine. I never really had problems. Early on I was still cramping and after a 
few months it went away. SOB wasn’t that bad. 
6) Do you think you are improving? Physically? Mentally? 
 Oh yeah. I'm definitely getting better. 
7) Did you get bored of this app and WT at any time? If so why 
 No I didn’t get bored. I got frustrated with the app when it was kicking me out. I 
didn't know if you guys were getting the info. 
8) Additional notes and comments 
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The app needs a little work but I can't be specific about what it needs. I thought it 
was a pretty good idea- the whole study. 
 
Patient 2 
1) What motivated you to walk? 
The schedule that is provided by the application. I also felt that people care about 
me and getting better. I was abandoned when I was born and spent about a year in 
the hospital, five years in the orphanage before I adopted at the age of 6 by 
parents who didn’t really want a kid. Their neighbor recently got a kid and to 
compete, they adopted me to show they had a kid too. 
2) Did it feel like a chore when you received the notification to do the WT? 
 No, I like it when people are interested in in my well fair. 
3) What kept you from doing the scheduled walk if you missed out on a week or so? 
[N/A, patient did most, if not all, scheduled walks.] 
4) What kept you from doing Open Walks if applicable? 
 My knees hurting, but it got resolved. 
5) How do you feel after/during each WT? 
Tired and short of breath, but I push myself despite the pain, because I know it’s 
good for me. 
6) Do you think you are improving? Physically? Mentally? 
 Yes, my left leg knee is getting better. 
7) Did you get bored of this app and WT at any time? If so why 
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 No. 
8) Additional notes and comments 
N/A 
 
Patient 3 
1) What motivated you to walk? 
Having to be able to keep track of it made me want to do it more than anything 
else. 
2) Did it feel like a chore when you received the notification to do the WT? 
My ankle is still bothering me, but other than that I am getting better, so it’s not as 
big of a challenge to do the Walk Tests when I’m notified. 
3) What kept you from doing the scheduled walk if you missed out on a week or so? 
It felt important to be able to keep track of what I am doing, and I wanted to feel 
like I was contributing. (Patient may have misinterpreted the question) 
4) What kept you from doing Open Walks if applicable? 
I just keep track of every time I go out, and developed a habit. (Patient may have 
misinterpreted the question) 
5) How do you feel after/during each WT? 
 During it, I am not really concentrating on the time limit, my mind just wanders. 
6) Do you think you are improving? Physically? Mentally? 
Definitely physically, and I hope mentally! This is something to do, a purpose, 
since I am no longer working anymore. 
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7) Did you get bored of this app and WT at any time? If so why 
I never got bored, I really liked it. I really like when the app tells me how much 
time is left on the walk test, it keeps me going. 
8) Additional notes and comments 
N/A 
 
Patient 4 
1) What motivated you to walk? 
You help the doctor out. 
2) Did it feel like a chore when you received the notification to do the WT? 
No burden. 
3) What kept you from doing the scheduled walk if you missed out on a week or so? 
Pain and shortness of breath. 
4) What kept you from doing Open Walks if applicable? 
It hurts due to my hip pain 
5) How do you feel after/during each WT? 
During it, I just want it to be over. I am frustrated with myself because I am 
unable to do it. After the walk, it is just a matter of catching my breathing. 
6) Do you think you are improving? Physically? Mentally? 
I think I am improving physically but the pain is still there.  Mentally, I expected 
more from myself. 
7) Did you get bored of this app and WT at any time? If so why 
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No, I did not get bored. I just got to be more initiative, I need to find my own 
motivation since I know pain from walking is coming. This is not about boredom, 
but more about dreading what it will feel like at the end of the walk. 
8) Additional notes and comments 
N/A 
 
Patient 5 
1) What motivated you to walk? 
Health, staying active, having an active lifestyle where I can climb mountains and 
skydive. I want to continue doing as much as I can in those sports. I also do not 
want to deal with Alzheimer’s or dementia since physical activity goes hand in 
hand with mental health. 
2) Did it feel like a chore when you received the notification to do the WT? 
No, it motivated me and reminded me to get active right now regardless of what I 
am doing. If you can, just do it. 
3) What kept you from doing the scheduled walk if you missed out on a week or so? 
Pain, extreme discomfort. I wanted to get up and do something but I was limited 
and impeded on my mobility. It was drastic, I have never been in this much pain 
all my life. I had complications after my surgery, it was very painful, swollen, so 
much pain. 
4) What kept you from doing Open Walks if applicable? 
Pain and discomfort. I really want to do Open Walks. 
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5) How do you feel after/during each WT? 
Accomplished. I just did something people think that I cannot do. I like to 
challenge people who think I can’t compete against younger people and prove 
them wrong. 
6) Do you think you are improving? Physically? Mentally? 
Yes, I feels like if I had to run from a dog, wild animal, or fire, I think I could. 
When you get physically stronger you become mentally stronger and then 
spiritually stronger. I don’t want people to stereotype me as “sick”, I don’t want 
people to be able to tell I am “sick”. 
7) Did you get bored of this app and WT at any time? If so why 
I did not get bored, I want to make the green circle go all the way at least one 
time. (points to the trackers inside the Apple Health App) Green is exercise, blue 
is standing, red is movement, I don’t even know how to use this application! 
(Built-in Apple Health App). 
8) Additional notes and comments 
I can now walk up 2 flight of stairs without my cane. I also don’t really get how to 
use this (phone). Technical difficulties. 
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